Company intelligence / Profile preview

Pop Venture

Buffalo, New York, United States

Ownership: Private
Development stage: Other

Overview

The company has demonstrated preclinical efficacy in vaccine and chemotherapy delivery platforms; awarded NIH and CEPI grants for rapid vaccine and immunotherapy programs and progressing toward human clinical trials for at least one program.

Therapeutic areas: Infectious DiseasesOncologyNeurology
Modalities: NanoparticleLiposome-based drug deliveryVaccineSmall molecule
Industry: Biotech

Partnerships

EuBiologicsFunPepCoalition for Epidemic Preparedness Innovations (CEPI)

Beyond the preview

Go deeper on Pop Venture.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pop Venture.

Explore the full profile